Page 39 - Axis Securities News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent and a net profit growth of 30.3 per cent for the third quarter of 2023-24 (FY24), riding on the approval for niche drugs in the US market, fall in raw material prices and correction in shipping rates. In the healthcare segment, hospitals are expected to post revenue growth of 13 per cent during the coverage, while net profit growth would be around 37 per cent, ICICI Securities said in a note. However, the performance may not be comparable on a sequential basis due to the offset of the festive season in Q3FY...

Analysts say that the outflow has been because of subdued corporate earnings visa-vis valuations, which has made investors cautious

Gold rate today is rising as the market is expecting an announcement of a rate cut schedule in the upcoming US Fed meeting, say experts

NALCO formed bullish candlestick pattern on the daily charts, with strong volumes. The stock traded well above all key moving averages (20, 50, 100 and 200-day EMA - exponential moving average), which is a positive sign.

HDFC Bank stock is trading at decadal-low valuations of about 2.1 times to book value. Not just LIC, but other long-term investors are finding value in the stock.